Fair value (multi-method)
Four independent methods triangulate what ABT is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$109.65
Method range
$20.33 – $169.37
median $118.56
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $109.65 | +20.40% |
| Exit multiple | $169.37 | +85.98% |
| Analyst target | $127.46 | +39.96% |
| Graham number | $20.33 | -77.67% |
- Forward DCF$109.65
- Exit multiple$169.37
- Analyst target$127.46
- Graham number$20.33
Stock price
$91.07
FCF / share (TTM)
$0.52
3Y FCF CAGR
-3.3%
Fair value @ hist. growth
$6.48
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
31.3%
per year over your projection horizon
Margin of safety -1305.0% vs hist-growth DCF
Historical 3Y CAGR
-3.3%
Your model implies
31.3%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at -3% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.8% | 26.6% | 25.2% | 23.6% | 21.7% | 19.5% |
| 6.8% | 30.2% | 29.0% | 27.7% | 26.3% | 24.6% |
| 7.8% | 33.3% | 32.3% | 31.3% | 30.1% | 28.8% |
| 8.8% | 36.2% | 35.3% | 34.4% | 33.4% | 32.4% |
| 9.8% | 38.9% | 38.1% | 37.3% | 36.5% | 35.6% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
Net debt
$6.5B
Total debt − cash
Beta
0.65
Vs market benchmark
Frequently asked questions
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation